Myeloid cell leukemia 1 (MCL-1), an unexpected modulator of protein kinase signaling during invasion
Author:
Affiliation:
1. Cancer Research Division, Garvan Institute of Medical Research and the Kinghorn Cancer Centre, 384 Victoria Street, Darlinghurst, NSW, Australia
2. St. Vincent's Clinical School, UNSW Medicine, Victoria Street, Darlinghurst, NSW, Australia
Funder
Cancer Council NSW
National Health and Medical Research Council
National Breast Cancer Foundation
Publisher
Informa UK Limited
Subject
Cell Biology,Cellular and Molecular Neuroscience
Link
https://www.tandfonline.com/doi/pdf/10.1080/19336918.2017.1393591
Reference103 articles.
1. MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib
2. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2.
3. Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases
4. Delving deeper: MCL-1's contributions to normal and cancer biology
5. The landscape of somatic copy-number alteration across human cancers
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. MCL1 inhibition: a promising approach to augment the efficacy of sorafenib in NSCLC through ferroptosis induction;Cell Death Discovery;2024-03-14
2. Inhibition of Multiple Myeloma Growth by Wogonin Involves Mitochondrial Apoptosis and G2/M Cycle Arrest;International Journal of Pharmacology;2024-02-01
3. SOHO State of the Art Updates and Next Questions: Understanding and Overcoming Venetoclax Resistance in Hematologic Malignancies;Clinical Lymphoma Myeloma and Leukemia;2024-01
4. MCL1 Inhibition: A Promising Approach to Augment the Efficacy of Sorafenib in NSCLC through Ferroptosis Induction;2023-09-25
5. MCL1 Inhibition Overcomes the Aggressiveness Features of Triple-Negative Breast Cancer MDA-MB-231 Cells;International Journal of Molecular Sciences;2023-07-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3